1. Enhancement of anti-tumor immunity in immunogenic and immune-refractory RAS mutant tumors with tri-complex RAS(ON) inhibitors. (October 2022) Authors: Blaj, C.; Menard, M.; Tobvis Shifrin, N.; Chen, K.; Chow, C.; Courtney, H.; Kumamoto, A.; Velilla, T.; Evans, J.W.; Lawrence, L.; Vonmelchert, B.; Kwok-Parkhill, A.; Singh, M.; Smith, J.A.; Quintana, E. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗